3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
13
Breast Neoplasms
9
Neoplasms
6
Lung Neoplasms
5
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Breast Neoplasms, Male
4
Squamous Cell Carcinoma of Head and Neck
3
Melanoma
3
Fallopian Tube Neoplasms
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Recurrence
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Inflammatory Breast Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Solid Tumor
1
Platinum-Refractory Fallopian Tube Carcinoma
1
Pancreatic Ductal Adenocarcinoma
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms, Basal Cell
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Interventions
sacituzumab govitecan
1
eribulin
1
balixafortide
1
Taxes
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Advanced Breast Cancer
×
Taxes
×
Clear all
NCT04826016
2023-03-20
POLTER
MedSIR
Phase 1/2
Withdrawn